Microbiologists

19-1022.00
Median wage $87,990/yr18,940 employed (US)Rank #555 of 923 scored · top 60% by substitution

Investigate the growth, structure, development, and other characteristics of microscopic organisms, such as bacteria, algae, or fungi. Includes medical microbiologists who study the relationship between organisms and disease or the effects of antibiotics on microorganisms.

Sub-scores

0–100 · band = confidence interval from rater disagreement

Substitution25
Exposure24
Augmentation63

Substitution — the headline: capability discounted by cost, barriers and adoption.

Exposure — technical capability alone, regardless of whether anyone deploys it.

Augmentation — how much AI assists without replacing. High here + moderate substitution = a changing job, not a disappearing one.

Tasks on the substitution scale

14 rated tasks, binned by substitution score.

Position among all scored occupations

Distribution of 923 occupation scores; the marker is this occupation.

Tasks with substitution ≥ 70

0%

Run 1.0.0-draft.1 · computed 2026-08-05 · rater panel: claude-sonnet-5, claude-haiku-4-5-20251001 · intervals span rater disagreement.

Why this score

The five weighted dimensions of the composite, averaged across this occupation's tasks (importance-weighted, panel mean). Exact weights and formulas: /api/v1/methodology.

Task automatabilityw 35%25

panel mean rating 2.0/5 → substitution pressure 25/100

Technical feasibility todayw 20%21

panel mean rating 1.9/5 → substitution pressure 21/100

Cost vs. human wagew 15%21

panel mean rating 1.8/5 → substitution pressure 21/100

Adoption barriersw 20%inverted — strong barriers lower the score30

panel mean rating 3.8/5 (barrier strength) → substitution pressure 30/100

Sector adoption velocityw 10%28

panel mean rating 2.1/5 → substitution pressure 28/100

Task breakdown (14 tasks)

Substitution pressure per task, weighted by O*NET importance in the composite. Expand a task for the full rater audit trail — every rating, every model, every rationale.

Study the structure and function of human, animal, and plant tissues, cells, pathogens, and toxins.

45

CI 25–65 · exposure 45 · augmentation 88 · importance 3.5/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510014/5Life sciences research and clinical microbiology labs have rapidly adopted automated image analysis, next-generation sequencing pipelines, and AI-assisted pathogen identification. High-digitization sectors (hospitals, biotech, genomics firms) show fast, measurable deployment of these tools in production workflows.
Sector adoption velocityclaude-sonnet-52/5Life sciences research is adopting AI for specific subtasks (protein structure prediction, image classification) but broad experimental biology work remains slow to digitize and automate at scale.
Augmentation potentialclaude-haiku-4-5-202510015/5AI dramatically augments microbiologist productivity: automated image segmentation and annotation accelerate microscopy work, AI-powered literature mining and sequence comparison assist hypothesis generation, and machine-learning-based pattern recognition in large datasets help humans identify novel structures and functions. The human microbiologist remains essential for experimental design and interpretation, but AI transforms throughput and discovery potential.
Augmentation potentialclaude-sonnet-54/5AI substantially assists via tools like AlphaFold, image analysis pipelines, literature mining, and data interpretation, meaningfully boosting researcher productivity even though humans remain central to the study design and execution.
Task automatabilityclaude-haiku-4-5-202510014/5AI systems can now automate significant portions of tissue and cell analysis through image recognition, pathogen identification via genomic sequencing analysis, and toxin classification. Modern computer vision and machine learning models trained on microscopy and histology data can perform comparative structural analysis and function prediction at scale with >50% time savings, though complex novel discoveries may still require human validation.
Task automatabilityclaude-sonnet-52/5This describes open-ended scientific investigation requiring wet-lab experimentation, hypothesis generation, and physical observation that AI cannot perform end-to-end; AI can assist literature review and data analysis but not the core empirical study.
Adoption barriersclaude-haiku-4-5-202510013/5While regulatory and liability barriers exist in clinical diagnostics requiring human sign-off, research and screening applications face fewer constraints. However, publication standards, institutional review boards, and the professional requirement for expert interpretation of novel findings introduce meaningful friction to full automation.
Adoption barriersclaude-sonnet-54/5Research involving pathogens/toxins is subject to biosafety regulations, institutional oversight, and often requires credentialed scientists to interpret and validate findings, creating substantial procedural barriers.
Cost vs. human wageclaude-haiku-4-5-202510014/5AI-based analysis of microscopy images and genomic sequences has become substantially cheaper than human expert time, particularly for high-volume screening and classification tasks. Sequencing automation and image analysis infrastructure, once built, cost a small fraction of equivalent specialist labor hours.
Cost vs. human wageclaude-sonnet-52/5Wet-lab equipment, reagents, and physical experimentation dominate costs; AI reduces some analysis time but the overall task still requires expensive human-run lab infrastructure, keeping cost savings modest.
Technical feasibility todayclaude-haiku-4-5-202510013/5Deployed products exist for specific subtasks—automated microscopy image analysis, genomic pathogen identification, and tissue classification systems are in use in clinical and research labs. However, these solutions have material limitations in generalization across novel organisms, tissue types, and edge cases, and they typically require expert human oversight rather than fully autonomous performance.
Technical feasibility todayclaude-sonnet-52/5AI tools exist for image analysis, sequence annotation, and literature synthesis but no deployed product autonomously conducts structural/functional studies of tissues, cells, pathogens, and toxins in production settings.

Prepare technical reports and recommendations, based upon research outcomes.

40

CI 30–50 · exposure 38 · augmentation 63 · importance 4.0/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5Academic and biotech sectors are exploring AI writing aids, but adoption remains limited to early pilots. Institutional conservatism, regulatory caution around research reporting, and the specialized nature of microbiology limit rapid deployment at scale.
Sector adoption velocityclaude-sonnet-53/5Scientific research settings are adopting AI writing and literature tools steadily, but full production-level reliance on AI-generated technical conclusions remains limited and cautious.
Augmentation potentialclaude-haiku-4-5-202510013/5Current AI can assist with outlining, drafting sections, formatting, and literature integration, measurably speeding up initial composition. However, the microbiologist must validate all technical claims and conclusions, limiting the productivity gain to perhaps 20–40% on the writing phase alone.
Augmentation potentialclaude-sonnet-54/5AI substantially helps with drafting, formatting, summarizing data, and literature contextualization, meaningfully speeding up the reporting process while the scientist retains final judgment.
Task automatabilityclaude-haiku-4-5-202510012/5Writing technical reports requires interpreting complex experimental data, synthesizing findings, and making judgments about significance—tasks that demand domain expertise and critical reasoning. Current AI can draft sections and organize information, but cannot independently validate scientific conclusions or ensure accuracy without substantial human review and correction.
Task automatabilityclaude-sonnet-53/5AI can draft technical report sections and summarize research findings, but interpreting novel data and forming validated recommendations requires domain expertise and judgment beyond current AI, so only partial time savings are achievable.
Adoption barriersclaude-haiku-4-5-202510013/5Regulatory and institutional oversight requirements for research reporting create friction: many organizations require scientist sign-off and authorship accountability. Liability concerns and the need for domain expertise to validate AI output prevent full automation, though assistance is acceptable.
Adoption barriersclaude-sonnet-53/5No strict licensing requirement for report writing itself, but scientific integrity, institutional review, and publication/regulatory standards create meaningful oversight friction.
Cost vs. human wageclaude-haiku-4-5-202510012/5The human time saved by AI assistance in drafting is modest—perhaps 20–30%—compared to the loaded cost of a microbiologist or technical writer. Integration, fact-checking, and oversight add costs that approach or exceed the savings from faster initial drafting.
Cost vs. human wageclaude-sonnet-53/5AI drafting tools reduce writing time at low incremental cost, but the requirement for expert review and validation keeps overall cost savings moderate rather than order-of-magnitude.
Technical feasibility todayclaude-haiku-4-5-202510012/5While AI writing tools exist, no deployed product reliably generates microbiological technical reports meeting publication or institutional standards autonomously. Systems require extensive fact-checking and domain validation, making them useful only as assisted drafting tools, not independent performers.
Technical feasibility todayclaude-sonnet-53/5LLM-based writing assistants and research summarization tools are used in labs today to draft reports, but scientists must heavily verify and rewrite content to ensure technical accuracy.

Examine physiological, morphological, and cultural characteristics, using microscope, to identify and classify microorganisms in human, water, and food specimens.

33

CI 25–41 · exposure 38 · augmentation 75 · importance 4.3/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510013/5Clinical diagnostics and food labs show moderate adoption of AI-assisted image analysis (pilots in reference labs), but most routine screening still relies on human microscopy; adoption has been slower than in other imaging domains due to regulatory constraints and quality-of-life preferences among technicians.
Sector adoption velocityclaude-sonnet-52/5Clinical/environmental microbiology labs are slower adopters of full AI automation compared to digital-native sectors, though some automated culture-reading systems are gaining traction in high-volume clinical microbiology labs.
Augmentation potentialclaude-haiku-4-5-202510014/5AI assists microbiologists substantially by pre-screening images, flagging candidate organisms, and reducing time spent on routine classification; systems can highlight uncertain cases for expert review, meaningfully raising technician throughput while keeping humans in charge of validation and ambiguous specimens.
Augmentation potentialclaude-sonnet-54/5AI-powered image analysis and pattern recognition tools can significantly speed up morphological identification and flag anomalies, meaningfully augmenting a microbiologist's throughput and accuracy while they retain final judgment.
Task automatabilityclaude-haiku-4-5-202510013/5AI systems can classify microorganisms from microscopy images with good accuracy on well-defined specimen types, but require setup for each context and struggle with ambiguous or novel morphologies; end-to-end automation including specimen preparation, slide imaging, and interpretation still requires ~40-50% human oversight, meeting partial automatability.
Task automatabilityclaude-sonnet-52/5Physical microscopy, sample handling, and culture examination require manual lab work that current AI cannot perform end-to-end; only the image interpretation/classification portion is automatable, and even that needs curated data pipelines and validation.
Adoption barriersclaude-haiku-4-5-202510014/5Clinical and food safety microbiology involves regulatory sign-off requirements (FDA, ISO standards); many jurisdictions legally require a licensed microbiologist to validate critical identifications, especially for food/water safety and medical diagnostics, creating hard barriers to full automation.
Adoption barriersclaude-sonnet-54/5Clinical and public health microbiology results often require certified lab personnel and regulatory compliance (e.g., CLIA), with liability for misidentification being high, creating strong barriers to full automation.
Cost vs. human wageclaude-haiku-4-5-202510012/5AI inference for image analysis is cheap, but integration with microscopy hardware, image acquisition, and required expert oversight for verification and edge cases means total cost per task remains roughly comparable to a trained microbiologist's labor, not a clear economic win.
Cost vs. human wageclaude-sonnet-52/5Automated imaging systems and AI classifiers require expensive specialized hardware, validation, and integration with lab workflows, so costs are not clearly lower than skilled technician/microbiologist time for this specific task.
Technical feasibility todayclaude-haiku-4-5-202510013/5Deep learning models for microscopy image classification exist in production (clinical labs, water testing), but error rates remain material (~5-15% misclassification) and performance narrows significantly outside training distributions; most deployed systems require human verification rather than full autonomy.
Technical feasibility todayclaude-sonnet-52/5AI-assisted microscopy image classification exists in research and some diagnostic products (e.g., automated blood smear or pathogen ID tools), but broad multi-specimen morphological/cultural characterization by microbiologists is not yet reliably automated in production across labs.

Isolate and maintain cultures of bacteria or other microorganisms in prescribed or developed media, controlling moisture, aeration, temperature, and nutrition.

28

CI 25–30 · exposure 25 · augmentation 50 · importance 4.6/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5Adoption is slow and concentrated in large pharma and biotech; smaller labs and academic institutions lag. Most cultures are still maintained manually despite decades of available automation technology, indicating deep organizational and training barriers.
Sector adoption velocityclaude-sonnet-52/5Lab automation adoption in microbiology/biotech is real but slow and capital-intensive, concentrated in large pharma/diagnostic labs rather than broadly across the field.
Augmentation potentialclaude-haiku-4-5-202510013/5Modern monitoring sensors, automated logging systems, and predictive analytics assist microbiologists by reducing manual record-keeping and alerting to drift in conditions. However, AI does not yet meaningfully assist in the core task of isolation and culture assessment.
Augmentation potentialclaude-sonnet-53/5AI-assisted protocol design, media optimization suggestions, and data logging can meaningfully support microbiologists, though the core physical culturing task itself sees less direct AI augmentation.
Task automatabilityclaude-haiku-4-5-202510012/5While some elements like temperature and aeration monitoring can be automated, isolating microorganisms and judging culture viability still require human expertise and physical manipulation. Current automation cannot reliably perform the full workflow—visual inspection, sterile technique, and real-time adjustments remain bottlenecks.
Task automatabilityclaude-sonnet-52/5Physical manipulation of cultures, aseptic technique, and hands-on monitoring of growth conditions require lab presence and dexterity that current AI cannot perform end-to-end; only planning/documentation portions are automatable.
Adoption barriersclaude-haiku-4-5-202510014/5Regulatory frameworks (GLP, USP, FDA 21 CFR Part 11) typically require documented human expertise and sign-off on culture work, especially in pharmaceutical and clinical settings. Liability for contamination or failed cultures creates institutional and legal friction against full automation.
Adoption barriersclaude-sonnet-53/5No licensing barrier per se, but biosafety protocols, contamination risk, and quality control in regulated environments (clinical/pharma) impose meaningful procedural friction against uninspected automation.
Cost vs. human wageclaude-haiku-4-5-202510012/5Initial investment in automation equipment (bioreactors, robotic arms, sensors) is substantial; integration and ongoing maintenance are costly. For many labs, the loaded wage of one microbiologist remains cheaper than the all-in cost of full system ownership and upkeep.
Cost vs. human wageclaude-sonnet-52/5Automated culturing systems require expensive capital investment (robotics, incubator integration) that is only cost-effective at high volume; for typical research-scale work, human technician labor remains cheaper than deploying/maintaining such systems.
Technical feasibility todayclaude-haiku-4-5-202510012/5Laboratory robots can execute repetitive steps (media preparation, incubation control) but no deployed system reliably handles the end-to-end isolation and culture maintenance task autonomously. Existing products target narrow subtasks; human microbiologists still supervise and intervene.
Technical feasibility todayclaude-sonnet-52/5Lab automation platforms (liquid handlers, automated incubators) exist and are used in some high-throughput settings, but general microbiologist culture work still relies heavily on manual technique in most labs.

Study growth, structure, development, and general characteristics of bacteria and other microorganisms to understand their relationship to human, plant, and animal health.

28

CI 25–30 · exposure 25 · augmentation 75 · importance 3.6/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5While research institutions use AI for image analysis and data mining, adoption of AI-driven automation in core microbiological research remains slow and limited to specialized, well-resourced labs. Most microbiologists continue traditional manual investigation; digital adoption patterns lag behind information-sector benchmarks.
Sector adoption velocityclaude-sonnet-52/5Life sciences research is adopting AI for specific analytical tasks (e.g., protein folding, image classification) but broad experimental microbiology remains slow to digitize compared to information-sector work.
Augmentation potentialclaude-haiku-4-5-202510014/5AI tools substantially augment microbiologist productivity through high-throughput image analysis, genomic database searches, pattern recognition in microscopy, and rapid literature synthesis. These assistive tools allow faster hypothesis generation and validation while the microbiologist retains intellectual control and experimental design authority.
Augmentation potentialclaude-sonnet-54/5AI substantially aids literature synthesis, data analysis, image recognition of microbial structures, and hypothesis generation, meaningfully boosting researcher productivity while humans remain central to experimentation.
Task automatabilityclaude-haiku-4-5-202510012/5While AI can assist with image analysis, data interpretation, and literature review, the core task requires hands-on experimental design, cultivation, observation of live microorganism behavior, and hypothesis formation that depend on tacit knowledge and real-time laboratory work. Current AI cannot autonomously conduct the full empirical cycle at equal quality.
Task automatabilityclaude-sonnet-52/5This is broad, open-ended scientific research involving wet-lab experimentation, hypothesis generation, and physical observation that AI cannot perform end-to-end; AI can assist analysis but not replace the core investigative work.
Adoption barriersclaude-haiku-4-5-202510014/5Microbiology research and clinical microbiology involve regulatory oversight (BSL-2/3 facilities, infection control standards), safety-critical judgment about pathogenic organisms, and professional accountability. Many jurisdictions require a licensed microbiologist or equivalent to oversee culture work and validate findings, creating meaningful legal and liability barriers.
Adoption barriersclaude-sonnet-53/5While no license is strictly required to 'study' microorganisms, publication, peer review, and institutional oversight of research create moderate friction against full automation.
Cost vs. human wageclaude-haiku-4-5-202510012/5AI-assisted image analysis and literature mining are inexpensive, but they supplement rather than replace the microbiologist's wet-lab work, expensive culture materials, and specialized equipment. The total cost of automation remains high relative to the wage savings from automating only portions of the task.
Cost vs. human wageclaude-sonnet-52/5Wet-lab equipment, sample handling, and expert interpretation still require human labor and physical infrastructure, so AI only reduces costs for narrow analytical sub-tasks rather than the whole task.
Technical feasibility todayclaude-haiku-4-5-202510012/5Computer vision tools exist for analyzing microscopy images and AI supports data processing, but no deployed product reliably performs the end-to-end study of microorganism growth and characteristics without expert microbiologist oversight and manual cultivation. Feasibility remains limited to narrow, post-hoc analysis rather than primary investigation.
Technical feasibility todayclaude-sonnet-52/5AI tools are used for literature review, image analysis, and genomic data interpretation, but no deployed product autonomously conducts microbiological research studies in production settings.

Conduct chemical analyses of substances such as acids, alcohols, and enzymes.

28

CI 25–30 · exposure 25 · augmentation 63 · importance 3.3/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5Laboratory work remains heavily dependent on hands-on, physical experimentation. While data management and informatics tools are increasingly used, the actual conduction of chemical analyses has not seen significant displacement by AI in production settings.
Sector adoption velocityclaude-sonnet-52/5Wet-lab science and clinical/research microbiology sectors adopt automation slowly compared to purely digital fields, with pilots of lab robotics but limited widespread production deployment.
Augmentation potentialclaude-haiku-4-5-202510013/5AI can meaningfully assist microbiologists by automating data interpretation, identifying patterns in results, flagging anomalies, and generating preliminary reports, thereby raising throughput and accuracy without removing the human from instrumental and quality-control decisions.
Augmentation potentialclaude-sonnet-54/5AI can meaningfully assist in analyzing spectral data, flagging anomalies, suggesting protocols, and drafting reports, boosting the microbiologist's productivity while they perform the physical assay work.
Task automatabilityclaude-haiku-4-5-202510012/5Chemical analyses require specialized laboratory instrumentation (HPLC, mass spectrometry, chromatography) and hands-on sample preparation that current AI cannot physically perform. While AI can assist in interpreting results and data analysis, the core task of conducting the actual chemical analysis remains firmly in the human/instrument domain.
Task automatabilityclaude-sonnet-52/5Physical sample handling, instrument operation, and wet-lab execution of chemical analyses require manual manipulation that current AI cannot perform end-to-end; AI can assist with data interpretation and reporting but not the physical assay work.It remains a lab-hands task.
Adoption barriersclaude-haiku-4-5-202510014/5Regulatory requirements (ISO certifications, GLP compliance, chain of custody) and quality assurance standards legally mandate that qualified personnel conduct and sign off on chemical analyses in regulated industries. Professional licensing and liability frameworks protect human technicians.
Adoption barriersclaude-sonnet-53/5While no formal license is required to run chemical analyses, quality control, safety protocols, and institutional validation requirements create moderate friction against full automation.
Cost vs. human wageclaude-haiku-4-5-202510012/5The cost of laboratory equipment, reagents, and sample preparation significantly exceeds the overhead of a trained microbiologist's labor. AI cannot replace the capital and consumable costs; it can only marginally reduce labor for result interpretation and reporting.
Cost vs. human wageclaude-sonnet-52/5Automated lab equipment and AI-assisted analysis tools have high capital and integration costs relative to a technician's wage for routine analyses, so cost savings are not yet dramatic for typical labs.
Technical feasibility todayclaude-haiku-4-5-202510012/5No deployed AI product performs end-to-end chemical analysis of substances. AI tools exist for result interpretation and data processing, but the instrumental measurement and wet-chemistry steps require human technicians and specialized equipment in production laboratories.
Technical feasibility todayclaude-sonnet-52/5Lab automation robots and analytical software exist but are narrow-purpose and not generally deployed to autonomously conduct full chemical analyses without human setup, calibration, and oversight.

Research use of bacteria and microorganisms to develop vitamins, antibiotics, amino acids, grain alcohol, sugars, and polymers.

26

CI 20–32 · exposure 20 · augmentation 75 · importance 3.7/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510013/5Pharmaceutical and biotechnology firms are actively piloting AI for computational phases (strain selection, pathway optimization) but full-scale experimental automation remains in development. Adoption is growing in high-value sectors but is not yet mainstream production at the task level.
Sector adoption velocityclaude-sonnet-52/5Biotech and pharma R&D are adopting AI for specific subtasks like protein modeling and literature synthesis, but wet-lab microbiology research overall remains a slower-adopting, hands-on discipline.
Augmentation potentialclaude-haiku-4-5-202510014/5AI strongly augments microbiologists by accelerating literature mining, suggesting candidate organisms and fermentation parameters, and analyzing complex datasets—all while the researcher remains responsible for design and execution. This assistive capability substantially raises productivity on hypothesis refinement and data interpretation.
Augmentation potentialclaude-sonnet-54/5AI significantly assists microbiologists through literature synthesis, experimental design suggestions, data analysis, and predictive modeling of molecular interactions, meaningfully speeding up parts of the research cycle.
Task automatabilityclaude-haiku-4-5-202510012/5While AI can assist with literature review, hypothesis generation, and data analysis, the core experimental work—culturing organisms, optimizing fermentation conditions, and iterating on biological systems—requires hands-on laboratory work that current AI cannot perform end-to-end. AI provides tools but does not meet the ≥50% time-saving threshold for the complete task.
Task automatabilityclaude-sonnet-52/5This is open-ended experimental research requiring hands-on lab work, novel hypothesis generation, and physical experimentation that current AI cannot perform end-to-end, though AI can assist with literature review and data analysis components.
Adoption barriersclaude-haiku-4-5-202510014/5Strong barriers exist: the research requires hands-on laboratory execution, institutional biosafety oversight, regulatory approval for novel organisms and products, and professional judgment on safety and efficacy. A qualified microbiologist and institutional protocols are legally and practically required; automation cannot circumvent these controls.
Adoption barriersclaude-sonnet-53/5No specific licensing bars AI from research, but scientific validity, safety protocols for biological work, and publication/peer-review norms create meaningful friction against pure AI substitution.
Cost vs. human wageclaude-haiku-4-5-202510012/5AI-assisted analysis and simulation reduce some costs (computational cycles, literature synthesis), but the core expense remains the trained microbiologist and lab infrastructure. AI overhead does not yet undercut the loaded wage of a skilled researcher, especially when accounting for integration and validation costs.
Cost vs. human wageclaude-sonnet-52/5AI tools for bioinformatics analysis are cheap, but the overall research task still requires expensive wet-lab work, expert oversight, and physical infrastructure that AI cannot substitute for, keeping overall cost savings limited.
Technical feasibility todayclaude-haiku-4-5-202510012/5Deployed AI products excel at information retrieval and computational prediction (protein folding, bioactivity modeling) but no mature end-to-end system reliably replaces the experimental design and wet-lab execution phases that define this research task. Current tools are auxiliary, not autonomous.
Technical feasibility todayclaude-sonnet-51/5No deployed product autonomously conducts microbiological research to develop new bioproducts; AI tools exist for narrow subtasks like sequence analysis but not the integrated research process.

Monitor and perform tests on water, food, and the environment to detect harmful microorganisms or to obtain information about sources of pollution, contamination, or infection.

25

CI 25–25 · exposure 25 · augmentation 50 · importance 4.3/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5While large municipal water systems and major food processors have adopted automated testing equipment, adoption remains piecemeal and focused on routine screening rather than autonomous investigation. Most smaller public health and environmental labs operate with manual methods; true AI-agent displacement is minimal.
Sector adoption velocityclaude-sonnet-52/5Environmental and public health microbiology labs are slow adopters of AI compared to information-sector fields, with automation mostly limited to data management and some robotic sample handling.
Augmentation potentialclaude-haiku-4-5-202510013/5AI-assisted microscopy image analysis and automated data flagging can meaningfully speed up sample processing and alert microbiologists to anomalies, but the human expert remains central to interpretation, confirmation testing, and source investigation. Augmentation is useful on detection subtasks but does not transform the full workflow.
Augmentation potentialclaude-sonnet-53/5AI can assist with pattern recognition in microscopy images, predictive contamination modeling, and data analysis, improving efficiency while humans still perform sampling and confirm results.
Task automatabilityclaude-haiku-4-5-202510012/5Sample preparation, culturing, and some routine microscopy/analytical detection can be partially automated with laboratory robots and AI image analysis, but environmental sampling, strategic test selection, and contamination source investigation require human judgment and interpretation of complex contextual data. Less than 50% of the end-to-end task is automatable at equal quality.
Task automatabilityclaude-sonnet-52/5Physical sampling, lab assay execution (culturing, PCR, sequencing), and instrument operation require hands-on manipulation that current AI cannot perform; AI can only assist with data analysis and interpretation portions.
Adoption barriersclaude-haiku-4-5-202510014/5Water quality testing, food safety, and epidemiological investigation are heavily regulated; regulatory agencies (EPA, FDA, CDC) mandate laboratory certification, chain-of-custody protocols, and licensed personnel sign-off on results. Liability for missed contamination is substantial, creating strong legal barriers to full automation.
Adoption barriersclaude-sonnet-54/5Public health and food/water safety testing is often regulated, requiring certified labs and credentialed personnel to sign off on results, creating strong liability and regulatory barriers to full automation.
Cost vs. human wageclaude-haiku-4-5-202510012/5Initial laboratory automation and AI imaging systems have high capital and maintenance costs; ongoing human expertise remains essential for decision-making and interpretation, making total cost per investigation comparable to or higher than human microbiologists for complex cases.
Cost vs. human wageclaude-sonnet-52/5Physical sampling, wet-lab work, and equipment costs dominate; AI only reduces a small analysis/reporting fraction of total cost, so overall savings versus human labor are modest.
Technical feasibility todayclaude-haiku-4-5-202510012/5AI-driven image analysis for microscopy exists and robotic liquid handlers are deployed in labs, but reliable, autonomous detection and source investigation of novel microbial threats or contamination patterns remains limited to narrow, standardized scenarios. Current products excel at specific subtasks but not the full workflow.
Technical feasibility todayclaude-sonnet-52/5Lab automation robots and AI-assisted diagnostic software exist for narrow assay types, but no deployed product performs full end-to-end environmental/food/water microbial testing reliably without human technicians.

Develop new products and procedures for sterilization, food and pharmaceutical supply preservation, or microbial contamination detection.

23

CI 16–30 · exposure 20 · augmentation 75 · importance 3.5/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5Pharmaceutical and food-safety R&D sectors are digitizing slowly relative to software/finance. Most microbiological product development remains labor-intensive, bench-based work in traditional lab settings. Adoption of AI-assisted tools is nascent and limited to data analysis and modeling, not autonomous product development.
Sector adoption velocityclaude-sonnet-52/5Biotech and pharma R&D are adopting AI tools for literature synthesis and molecule screening, but adoption in applied microbiology product development remains at pilot stage rather than deep integration.
Augmentation potentialclaude-haiku-4-5-202510014/5AI can meaningfully augment microbiologists through rapid literature mining, predictive modeling of sterilization efficacy, simulation of microbial contamination scenarios, and analysis of experimental data. These aids accelerate hypothesis generation and reduce repetitive analysis, allowing scientists to focus on novel experimental design and validation.
Augmentation potentialclaude-sonnet-54/5AI can significantly speed up literature reviews, hypothesis generation, experimental design suggestions, and data analysis, meaningfully boosting researcher productivity while humans retain control of experimentation and validation.
Task automatabilityclaude-haiku-4-5-202510012/5While AI can assist with literature review, data analysis, and predictive modeling of sterilization parameters, the core creative work of developing novel sterilization products/procedures and designing new detection methods requires wet-lab experimentation, hands-on troubleshooting, and domain judgment that current AI cannot perform end-to-end. AI cannot independently design, build, and validate new physical or chemical processes.
Task automatabilityclaude-sonnet-52/5This is a creative, experimental R&D task requiring hands-on lab work, hypothesis generation, and iterative validation that current AI cannot execute end-to-end, though it can assist with literature review and hypothesis brainstorming.
Adoption barriersclaude-haiku-4-5-202510014/5Regulatory approval for new sterilization and pharmaceutical preservation products is stringent (FDA, ISO standards). Documentation, validation studies, and regulatory sign-off require human expertise and accountability. The task also demands hands-on laboratory work and professional judgment that cannot be legally or practically delegated to automation.
Adoption barriersclaude-sonnet-53/5While no license is strictly required to 'develop' a product, regulatory approval pathways (FDA, EPA) for sterilization/preservation products impose significant validation and documentation requirements that favor human expert oversight.
Cost vs. human wageclaude-haiku-4-5-202510011/5The task involves months to years of specialized R&D labor by highly trained microbiologists. AI computational aids are negligible in cost compared to the loaded wage of experienced product-development scientists, and do not offset the core human effort required.
Cost vs. human wageclaude-sonnet-52/5AI can cheaply assist with background research and data analysis, but the core wet-lab development and validation still requires expensive skilled scientists and equipment, keeping overall cost comparable or AI-cheaper only for a small slice of the task.
Technical feasibility todayclaude-haiku-4-5-202510012/5No deployed AI system can autonomously develop new sterilization or contamination-detection products or procedures. Researchers use AI tools for analysis and simulation, but product development remains a human-led, hands-on process requiring laboratory work and iterative hypothesis testing that AI cannot execute independently.
Technical feasibility todayclaude-sonnet-51/5No deployed product autonomously develops novel sterilization or preservation products/procedures; this remains firmly in the research-assistance stage, not production automation.

Investigate the relationship between organisms and disease, including the control of epidemics and the effects of antibiotics on microorganisms.

23

CI 20–25 · exposure 20 · augmentation 75 · importance 4.1/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5While AI-assisted bioinformatics is growing in research labs, actual displacement of microbiological investigation work remains minimal; adoption is concentrated in data analysis phases rather than the core investigative and control functions, and progress is measured in years, not rapid deployment.
Sector adoption velocityclaude-sonnet-52/5Academic and public health microbiology research adopts AI tools slowly and unevenly, with pilots for literature review and bioinformatics but little production-scale deployment for core research tasks.
Augmentation potentialclaude-haiku-4-5-202510014/5AI significantly augments microbiologist productivity through rapid literature synthesis, genomic alignment, epidemiological modeling, antibiotic resistance pattern detection, and real-time data dashboard generation—enabling faster hypothesis formation and evidence evaluation while the scientist retains design and interpretation authority.
Augmentation potentialclaude-sonnet-54/5AI substantially assists literature synthesis, sequence analysis, hypothesis generation, and data pattern recognition, meaningfully boosting researcher productivity while humans retain control of experimental design and interpretation.
Task automatabilityclaude-haiku-4-5-202510012/5While AI can assist with literature analysis, data interpretation, and pattern recognition in epidemiological datasets, the core investigative work—designing experiments, formulating novel hypotheses about organism-disease relationships, and interpreting unexpected results—requires human scientific judgment and hands-on laboratory validation that current AI cannot perform autonomously.
Task automatabilityclaude-sonnet-52/5This is open-ended scientific research requiring hypothesis generation, wet-lab experimentation, and interpretation of novel biological phenomena, which current AI cannot execute end-to-end.imony AI can assist with literature review and data analysis but not the core investigative work.But no full automation exists.rest is minor.the task retains a low rating.the physical experimentation cannot be automated.the analysis of results also requires expert judgment.overall automatability stays low.the task is not close to 50% time savings at equal quality across the whole task.hence rating 2.
Adoption barriersclaude-haiku-4-5-202510014/5Regulatory oversight (CDC, FDA, institutional biosafety committees), professional licensing requirements, liability for incorrect epidemiological conclusions, and the requirement for credentialed scientists to design and sign off on studies create substantial legal and organizational barriers to full automation.
Adoption barriersclaude-sonnet-54/5Research involving pathogens, epidemic control, and antibiotic efficacy is subject to biosafety regulations, institutional review, and professional certification requirements, creating strong barriers to full automation.
Cost vs. human wageclaude-haiku-4-5-202510012/5The cost of AI infrastructure and specialized bioinformatics pipelines, combined with required expert human oversight and validation, approaches or exceeds the cost of the microbiologist's time; there is no clear cost advantage.
Cost vs. human wageclaude-sonnet-52/5AI tools (literature mining, bioinformatics analysis) are cheap for narrow subtasks, but the overall research process still requires costly skilled labor, lab infrastructure, and oversight, keeping total cost comparable to or only modestly below human-only costs.
Technical feasibility todayclaude-haiku-4-5-202510012/5Deployed AI tools exist for literature mining and genomic analysis, but no end-to-end product reliably performs original microbiological investigation or epidemic control decision-making independently; these tasks remain primarily human-driven with AI in supporting roles only.
Technical feasibility todayclaude-sonnet-51/5No deployed product autonomously investigates organism-disease relationships or designs epidemic control studies; this remains research-stage capability requiring human scientists to design and run experiments.

Provide laboratory services for health departments, community environmental health programs, and physicians needing information for diagnosis and treatment.

21

CI 16–25 · exposure 25 · augmentation 50 · importance 4.3/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5Clinical and public health microbiology remains a human-centric, regulation-bound sector. While some labs have adopted automated analyzers for specific assays, wholesale displacement of microbiologist tasks is not occurring; adoption is limited to incremental instrument and informatics upgrades.
Sector adoption velocityclaude-sonnet-52/5Public health and clinical laboratory sectors adopt digital tools cautiously due to regulatory oversight and validation requirements, with AI integration still largely at the pilot stage.
Augmentation potentialclaude-haiku-4-5-202510013/5AI can assist by automating image analysis of microscopy slides, flagging anomalies, and generating preliminary diagnostic suggestions from test patterns, reducing manual review time. However, the core cognitive work of interpretation and the physical lab work still require human oversight and decision-making.
Augmentation potentialclaude-sonnet-53/5AI can assist with data analysis, pattern recognition in microbial identification, and report generation, improving efficiency while the microbiologist retains responsibility for testing and diagnosis decisions.
Task automatabilityclaude-haiku-4-5-202510012/5Laboratory work requires hands-on specimen handling, culturing, and microscopic/instrumental analysis that AI cannot perform physically today. While AI can assist in data interpretation and reporting, the core technical procedures (sample preparation, incubation, testing) remain fundamentally manual and require human execution in the lab.
Task automatabilityclaude-sonnet-52/5This task bundles physical lab work (sample handling, culturing, testing) with interpretation and communication to clients, most of which requires hands-on execution and professional judgment that current AI cannot perform end-to-end.
Adoption barriersclaude-haiku-4-5-202510015/5Clinical laboratory services are heavily regulated (CLIA in the US, equivalent standards elsewhere), requiring licensed professionals to perform and certify results. Liability and regulatory requirements mandate human microbiologists or certified technicians sign off on diagnostic findings; automation cannot bypass these legal and quality assurance barriers.
Adoption barriersclaude-sonnet-54/5Clinical and public health lab results require certified personnel, accreditation (CLIA-type regulations), and liability accountability, creating strong regulatory and licensing barriers to full automation.
Cost vs. human wageclaude-haiku-4-5-202510011/5AI assistance in reporting and data interpretation is nascent and cost-competitive only for narrow subtasks; the loaded cost of a microbiologist or technician performing the full service remains far below what automation of specialized lab workflows currently costs to integrate and maintain.
Cost vs. human wageclaude-sonnet-52/5Physical lab infrastructure, reagents, equipment, and technician labor dominate cost; AI can reduce some analysis time but does not eliminate the bulk of cost drivers, so overall savings are modest.
Technical feasibility todayclaude-haiku-4-5-202510012/5AI tools exist for microscopy image analysis and some diagnostic pattern recognition, but no deployed product can perform the full spectrum of microbiological testing (cultures, sensitivity testing, identification) end-to-end without human technician involvement. Clinical labs still rely on human judgment and hands-on execution.
Technical feasibility todayclaude-sonnet-52/5Some AI-assisted diagnostic tools (e.g., image-based pathogen identification) exist in narrow research or pilot deployments, but no product independently provides full laboratory services to health departments and physicians today.

Observe action of microorganisms upon living tissues of plants, higher animals, and other microorganisms, and on dead organic matter.

16

CI 7–25 · exposure 13 · augmentation 63 · importance 3.7/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5While research labs use automated microscopy for imaging, the live observation and interpretation of microbial action remains largely manual in production settings. Adoption is limited to high-throughput screening in specialized contexts, not widespread deployment across microbiological practice.
Sector adoption velocityclaude-sonnet-52/5Life sciences research is adopting AI for data analysis and image classification but the physical observation and experimental work itself sees slow, limited AI integration.
Augmentation potentialclaude-haiku-4-5-202510013/5AI-assisted image analysis and automated microscopy data collection can meaningfully speed up the preliminary observation phase, allowing microbiologists to focus on interpretation and experimental design. However, the assistive gain is moderate since human expertise remains central to understanding microbial behavior.
Augmentation potentialclaude-sonnet-54/5AI-powered image analysis, pattern recognition in microscopy, and literature synthesis can meaningfully assist microbiologists in interpreting and documenting observations.
Task automatabilityclaude-haiku-4-5-202510012/5Current AI cannot independently observe live microbial interactions in real time or interpret dynamic cellular/tissue responses. While image analysis can categorize static microscopy images, the continuous monitoring and adaptive interpretation required for observing complex biological action remains beyond autonomous AI capability today.
Task automatabilityclaude-sonnet-51/5This requires physical laboratory observation of microorganism interactions with living tissue, involving hands-on experimentation, microscopy, and real-time judgment that current AI cannot perform end-to-end.
Adoption barriersclaude-haiku-4-5-202510014/5Professional licensing (microbiology certifications), regulatory requirements for biological safety protocols, liability for misidentification of pathogens, and the need for expert interpretation create substantial legal and organizational barriers to full autonomous substitution.
Adoption barriersclaude-sonnet-54/5Requires specialized training, lab safety protocols, and scientific credibility/certification for research validity, though not a strict licensing requirement like medicine or law.
Cost vs. human wageclaude-haiku-4-5-202510012/5Automated microscopy and image analysis carry significant capital and integration costs. For the comprehensive observational interpretation required, human microbiologists remain more cost-effective than the full AI system needed (hardware, software, validation, expert review).
Cost vs. human wageclaude-sonnet-51/5AI cannot substitute for the physical apparatus, reagents, and skilled hands-on observation required, so there is no viable cost comparison for full task replacement.
Technical feasibility todayclaude-haiku-4-5-202510012/5Deployed microscopy systems can acquire and automatically classify microbial images, but no product reliably performs the full task of observing and interpreting the detailed biological action of microorganisms on living systems without expert oversight. Research tools exist but are not production-ready for autonomous observation.
Technical feasibility todayclaude-sonnet-51/5No deployed product performs physical biological observation and experimentation; this remains firmly in the domain of human wet-lab work.

Use a variety of specialized equipment, such as electron microscopes, gas and high-pressure liquid chromatographs, electrophoresis units, thermocyclers, fluorescence-activated cell sorters, and phosphorimagers.

14

CI 7–21 · exposure 13 · augmentation 50 · importance 4.2/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510012/5While digitization of lab processes is advancing, adoption of AI-driven autonomous equipment operation remains limited to narrow, well-defined tasks (e.g., liquid handling) in specialized facilities; most microbiology labs still rely on human operators for complex instrument workflows.
Sector adoption velocityclaude-sonnet-52/5Laboratory science remains a physically-grounded, equipment-intensive sector where AI adoption for actual instrument operation is minimal despite growth in data-analysis tooling.
Augmentation potentialclaude-haiku-4-5-202510013/5AI can assist by automating sample preparation workflows, optimizing instrument parameters based on historical data, and flagging anomalies in real-time results, moderately enhancing operator productivity without removing the human from critical decisions and quality control steps.
Augmentation potentialclaude-sonnet-53/5AI can assist with interpreting outputs (e.g., spectra, chromatograms, imaging data) and automating data logging, but does not touch the physical operation of the equipment itself.
Task automatabilityclaude-haiku-4-5-202510012/5Operating specialized laboratory equipment requires physical manipulation, calibration, maintenance, and real-time troubleshooting that remains beyond current robotic capabilities in most research environments. While AI can assist with protocol planning and data interpretation, the hands-on operation of electron microscopes, thermocyclers, and cell sorters requires embodied control that today's systems cannot reliably perform end-to-end.
Task automatabilityclaude-sonnet-51/5This is a physical, hands-on task requiring manual manipulation of lab equipment, sample preparation, and instrument operation, which current AI systems cannot perform end-to-end.
Adoption barriersclaude-haiku-4-5-202510014/5Regulatory frameworks (FDA, EPA, ISO standards) often require documented operator competency and signed records of procedures and results; institutional liability and validation requirements for analytical methods create strong legal barriers to substitution by autonomous systems.
Adoption barriersclaude-sonnet-54/5Operating specialized lab equipment typically requires trained personnel, safety protocols, and institutional certification, with high liability for errors in scientific data generation.
Cost vs. human wageclaude-haiku-4-5-202510011/5Specialized laboratory equipment requires expensive hardware integration, calibration, and maintenance oversight that currently exceeds the cost of employing trained microbiologists who already possess domain expertise and can switch between instruments.
Cost vs. human wageclaude-sonnet-51/5AI cannot substitute for the physical operation of this equipment, so there is no viable AI-based cost alternative to the trained human operator.
Technical feasibility todayclaude-haiku-4-5-202510012/5Few deployed products can autonomously operate the full range of specialized equipment mentioned; some lab automation exists for liquid handling and thermocyclers, but integration across diverse instruments and adaptation to variable experimental conditions remains research-stage in most organizations.
Technical feasibility todayclaude-sonnet-51/5No deployed AI product operates electron microscopes, chromatographs, or cell sorters autonomously; these remain human-operated instruments with software-assisted data analysis at best.

Supervise biological technologists and technicians and other scientists.

4

CI 0–7 · exposure 0 · augmentation 38 · importance 4.2/5 · click for rater detail

Panel ratings per dimension for this task
DimensionModelRatingRationale
Sector adoption velocityclaude-haiku-4-5-202510011/5Personnel supervision is a core human management function with no meaningful AI displacement in any sector; organizations universally retain human supervisors by legal and operational necessity.
Sector adoption velocityclaude-sonnet-52/5While AI tools are being piloted in lab settings for scheduling and monitoring, actual supervisory/managerial functions over staff show little to no AI-driven displacement in life sciences sectors.
Augmentation potentialclaude-haiku-4-5-202510012/5AI tools can assist supervisors with scheduling, documentation, or performance data aggregation, but such support is marginal and does not materially transform supervision capability given its inherently relational nature.
Augmentation potentialclaude-sonnet-53/5AI can assist with scheduling, tracking technician performance metrics, training material generation, and administrative aspects of supervision, improving efficiency without replacing the supervisory role itself.
Task automatabilityclaude-haiku-4-5-202510011/5Supervision inherently requires human judgment, interpersonal interaction, conflict resolution, and accountability that current AI cannot perform end-to-end. AI lacks the authority structure and contextual understanding necessary to manage personnel effectively.
Task automatabilityclaude-sonnet-51/5Supervision of technical staff requires interpersonal leadership, performance evaluation, mentoring, and judgment calls that AI cannot perform end-to-end today.:
Adoption barriersclaude-haiku-4-5-202510015/5Legal and organizational structures explicitly require a human supervisor to hold accountability for personnel management, safety oversight, and institutional liability. Regulatory and contractual frameworks mandate human supervisory sign-off.
Adoption barriersclaude-sonnet-54/5Supervisory authority typically requires organizational accountability, HR/legal responsibility for personnel decisions, and often credentialed oversight of technical work, creating strong structural barriers to automation.
Cost vs. human wageclaude-haiku-4-5-202510011/5AI cannot legally or effectively substitute for a human supervisor, making direct cost comparison unfeasible. The loaded cost of a microbiologist-supervisor is not comparable to inference costs for an incapable system.
Cost vs. human wageclaude-sonnet-51/5There is no AI system that can replace the cost of a human supervisor for personnel management, so the comparison favors the human at all-in cost.
Technical feasibility todayclaude-haiku-4-5-202510011/5No deployed AI systems reliably perform personnel supervision at scale; this task requires legal accountability and human trust that no current product can replace. Supervision remains an exclusively human function in production settings.
Technical feasibility todayclaude-sonnet-51/5No deployed product manages or supervises human laboratory staff; this remains a human management function with no substitute product on the market.

Related occupations — Life, Physical & Social Science

How to read this

A high substitution score does not mean this job disappears — it means a large share of its current tasks face replacement pressure, so the mix of tasks is likely to change. High augmentation alongside substitution typically means the occupation reorganizes around the protected tasks. Wide confidence intervals mean the rater panel disagreed: treat those scores as open questions, not verdicts.

What would change this score

New model capabilities (automatability, feasibility), falling inference costs (cost ratio), regulation and licensing shifts (barriers), and measured sector adoption (velocity) all re-enter at every index release. Each release is recomputed, versioned and kept queryable — scores are claims with a date on them, not permanent labels.